Markets:

Overview

News

Currencies

International

Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

45.67 +0.24 (+0.53%)

Streaming Delayed Price Updated: 2:59 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 Next >

See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate ↗

August 31, 2021

AC Immune SA (NASDAQ: ACIU) and its collaborating partner Genentech, part of Roche Holdings AG (OTC: RHHBY), have announced topline data from Phase...

Via Benzinga

After Bladder Cancer, Roche Pulls Breast Cancer Indication For Tecentriq In US ↗

August 27, 2021

Following a consultation from the FDA, Roche Holdings AG (OTC: RHHBY) has decided to withdraw its immunotherapy, Tecentriq (atezolizumab), to treat a type of...

Via Benzinga

Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

August 27, 2021

From Genentech

Via Business Wire

Shape Therapeutics, Roche Form $3B RNA Editing Collaboration ↗

August 24, 2021

Shape Therapeutics Inc announced a multi-target strategic collaboration and license agreement with Roche Holding AG (OTC: RHHBY) for RNA editing technology....

Via Benzinga

UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail ↗

August 20, 2021

The U.K. drug regulator has approved an antibody cocktail developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Roche Holding AG (OTC: RHHBY) to prevent...

Via Benzinga

Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage ↗

August 17, 2021

Roche Holdings AG's (OTCQX: RHHBF) drug Actemra, or tocilizumab, was granted FDA emergency use authorization for critically ill COVID-19 patients after...

Via Benzinga

AstraZeneca, Daiichi Sankyo's Enhertu Shows Improved PFS Over Roche's Kadcyla In Breast Cancer ↗

August 09, 2021

AstraZeneca plc (NASDAQ: AZN) and Daiichi Sankyo Co Ltd (OTC: DSKYF) have announced high-level results from the head-to-head DESTINY-Breast03 Phase 3...

Via Benzinga

Genentech's Polivy Plus R-CHP Shows Prolonged Survival In Newly Diagnosed DLBCL Patients ↗

August 09, 2021

Genentech, a member of Roche Holdings AG (OTC: RHHBY), announced that the pivotal Phase 3 POLARIX trial met its primary endpoint in people with previously...

Via Benzinga

Phase III Study Shows Genentech's Polivy Plus R-CHP Is the First Regimen in 20 Years to Significantly Improve Outcomes in Previously Untreated Aggressive Form of Lymphoma Compared to Standard of Care

August 09, 2021

From Genentech

Via Business Wire

These OTC Securities Had the Most Trading Activity in July ↗

August 06, 2021

Photo by Federico Beccari on Unsplash In July, O...

Via Benzinga

Moderna Vs. BioNTech: How Do These High-Flying COVID-19 Vaccine Stocks Compare? ↗

August 04, 2021

Moderna, Inc. (NASDAQ: MRNA) and BioNTech SE (NASDAQ: BNTX) shares have been on tear ever since these companies embarked on their respective COVID-19 vaccine programs. Shares of...

Via Benzinga

Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg ↗

August 04, 2021

SoftBank Group Corp (OTC: SFTBF) has quietly acquired a $5 billion stake in Roche Holdings AG (OTC: RHHBF), making it one of the largest investors of the Roche,...

Via Benzinga

Outlook Therapeutics Stock Surges Positive ONS-5010 Data In Wet AMD Patients ↗

August 03, 2021

Outlook Therapeutics Inc (NASDAQ: OTLK) stock is trading higher in premarket session in reaction to positive top-line results from Phase 3 NORSE TWO trial...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Roche's Tecentriq As Adjuvant Treatment Under Priority Review With FDA For Early Lung Cancer ↗

August 03, 2021

The FDA has granted priority review for Genentech's, a unit of Roche Holdings AG (OTC: RHHBY) Tecentriq (atezolizumab), as adjuvant treatment for...

Via Benzinga

FDA Grants Priority Review to Genentech’s Tecentriq as Adjuvant Treatment for Certain People With Early Non-small Cell Lung Cancer

August 03, 2021

From Genentech

Via Business Wire

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis ↗

August 02, 2021

Following the June update that

Via Benzinga

How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market ↗

July 29, 2021

Venclexta's potential indication for the treatment of myelodysplastic syndrome could mean billions for AbbVie this decade.

Via The Motley Fool

Roche's Faricimab US Application For Ocular Diseases Under Priority Review ↗

July 29, 2021

The FDA has accepted Roche Holding AG's (OTC: RHHBY) Biologics License Application seeking approval for faricimab in neovascular of wet age-related macular...

Via Benzinga

FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)

July 29, 2021

From Genentech

Via Business Wire

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Data for Genentech’s Evrysdi (risdiplam) Published in New England Journal of Medicine Shows Significant Improvement in Survival and Motor Milestones in Babies With Type 1 Spinal Muscular Atrophy (SMA)

July 28, 2021

From Genentech

Via Business Wire

OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities ↗

July 28, 2021

Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility...

Via Benzinga

Infinity Pharma Stock Drops After Updated Data From Bladder & Breast Cancer Trials, Q2 Earnings ↗

July 27, 2021

Infinity Pharmaceuticals Inc (NASDAQ: INFI) has issued data updates from two mid-stage trials for eganelisib, its oral immuno-oncology candidate. Data: 49...

Via Benzinga

Joblessness Surprise ↗

July 22, 2021

Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.

Via Talk Markets

Roche Puts Alzheimer's Candidate, Gantenerumab In Spotlight; In Dialogue with FDA: Reuters ↗

July 22, 2021

Roche Holding AG (OTC: RHHBY) is reportedly talking to the FDA about its Alzheimer’s disease drug candidate, gantenerumab. CEO Severin Schwan declined...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2021 ↗

July 22, 2021

Upgrades According to Stephens & Co., the prior rating for World Acceptance Corp (NASDAQ:...

Via Benzinga

Rebound In COVID-19 Tests Lift Roche's Half-Year Sales, Oncology Still Hit By Biosimilars, Pandemic ↗

July 22, 2021

Roche Holding AG's (OTC: RHHBY) 1H 2021 sales increased by 8% Y/Y at constant exchange rates (CER) to CHF 30.7 billion as peak demand for COVID-19 tests helped...

Via Benzinga

Panic Attack ↗

July 21, 2021

The H1 rise in US markets was based on hope for an end to lockdowns.

Via Talk Markets

< Previous 1 2

...

27 28 29 30 31 32 33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.